Davis Polk, Latham advise on Venus Medtech‘s $331 mln Hong Kong IPO
BY Aparna Sai |
Davis Polk and King & Wood Mallesons have represented Chinese medical device manufacturer Venus Medtech on its $331.17 million initial public offering on the Hong Kong Stock Exchange, with Latham & Watkins and Jingtian & Gongcheng advising the joint sponsors.